Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. - Wikidata - wikimedia - TriplyDB

Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

http://www.wikidata.org/entity/Q33588560

about

Urinary Tract Infection Molecular Mechanisms and Clinical Translation From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Urinalysis and Clinical Correlations in Patients with P. vivax or P. falciparum Malaria from Colombia Host imprints on bacterial genomes--rapid, divergent evolution in individual patients Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection.Genetic control of the variable innate immune response to asymptomatic bacteriuria How to make it in the urinary tract: a tutorial by Escherichia coli Genomic analysis of between-cow variation in dermal fibroblast response to lipopolysaccharide.Genetic polymorphisms in Toll-like receptors among pediatric patients with renal parenchymal infections of different clinical severities.Association of Toll-like receptor polymorphisms with HIV status in North Americans Innate immunity and genetic determinants of urinary tract infection susceptibility.Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes.TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets.A Murine Model for Escherichia coli Urinary Tract Infection.Toll-like receptor signaling in primary immune deficiencies.Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.The Genetics of Urinary Tract Infections and the Innate Defense of the Kidney and Urinary tract Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation Effects of polymorphisms of innate immunity genes and environmental factors on the risk of noncardia gastric cancer.Genetics of innate immunity and UTI susceptibility.Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections.From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.Single Nucleotide Polymorphisms in 5' Upstream Region of Bovine TLR4 Gene Affecting Expression Profile and Transcription Factor Binding Sites.TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis.Urinary NGAL deficiency in recurrent urinary tract infections.IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections.[Pathogenesis of urinary tract infections : An update].Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice.Polymorphism -2604G>A variants in TLR4 promoter are associated with different gene expression level in peripheral blood of atherosclerotic patients.Uropathogenic Escherichia coli infection: potential importance of epigenetics.Toll-like receptor 4 (TLR4) polymorphisms in Iranian patients with visceral leishmaniasis.Uropathogenic bacteria leave a mark.A Putative Role of Apolipoprotein L1 Polymorphism in Renal Parenchymal Scarring Following Febrile Urinary Tract Infection in Nigerian Under-Five Children: Proposal for a Case-Control Association Study.

P2860

Q26765423-84DD712A-3D17-4305-A6FE-0EE6D19611B9 Q30424697-8F5AF349-5651-46DF-8E7D-EC48E4AD1691 Q33442845-67CB31D1-07AA-44A1-B946-898860EE8BDA Q33701690-EE0183F2-971A-4D9B-976B-A3128517CD3C Q33707731-E8BAC9F0-FB5F-4655-A930-AE9E79B0EEC9 Q34091450-A4CE4A15-0B3D-4E24-9400-772BEDE3787D Q34440629-7919945A-6F86-4D1C-9FA1-260B10B93C98 Q34530214-57221CB4-6598-43A2-A86B-071003403D7A Q34618938-D418B131-5E18-4662-9851-59E248C4804B Q34642208-B31BD5D6-0029-46F5-9369-9831B35F2860 Q34856462-A48BE7D2-5927-4E84-AC7F-BF142A82388D Q35439695-434CF166-D047-4FB0-87CB-6CA2C5ABD56D Q35689537-2DA71E10-A2F6-419A-B9F9-B773BEAC72A3 Q35819527-AF3A1BE2-60E0-4130-8606-1BD89CE2FD7C Q35852635-77EBF9E4-9797-498F-9BF5-C80ADD2E3487 Q35903739-3B6CADFF-B2D0-4B6C-8A53-D7BE396D75EA Q36219597-49954713-2F8A-4750-9E49-FFCE57FEA64F Q36238886-A7C452BB-DB9B-43A8-B62D-45310AD505CE Q36457770-D2D5C8CD-6531-42A3-B5FF-8E4643514376 Q36634934-34563713-51D4-4F09-BADF-9E424213EC22 Q36910650-671E07C2-AE0B-4876-B136-E2015CFAABAC Q37032677-750B194D-4FBF-4BAD-9829-45BBE000C10B Q37139589-9DA5A503-E84C-41DC-B812-F1D717190C42 Q37204032-7977C83B-2B57-4165-BB51-E208B5D8CC01 Q37484582-318B0A8D-31BC-473B-8B9B-8CE4AF76239F Q37900471-44BB99A5-804F-4BCB-95EA-2A8427632EEF Q37983470-E3E5BC26-1117-4971-8AFA-B41ACFBB3475 Q38142595-E7033B76-1842-474C-8D31-19B598089D87 Q38673317-A49BAA2A-C7C3-447B-B5DF-377CF62E9A4A Q38739420-43AD6407-87DC-47BE-AFD1-25831E7B33EE Q38955940-EE10A979-03AD-4F8C-866E-E6C188A2BEF4 Q39815392-B9F137D8-6F6D-48DF-A1E9-B8FFC97360A2 Q40233051-0E8E1207-DDBF-44A6-BF7D-06D3A9259A31 Q40359137-F71938DB-384F-4C0B-BBFA-1FA82DA92152 Q44504933-5A4FB85A-6631-4704-BF90-15F26AEA39E2 Q47981291-36CFD667-CA4A-45AE-8E88-2663A879BD27 Q54288276-18FEA6B0-72DE-4043-84F0-9AA56C836F97 Q54360618-BC164803-879B-43BB-A746-6A96A176F2E0 Q55432505-3A3DB5E0-A43C-4C1E-B0DD-79E0C68AC2D5

P2860

Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

http://www.wikidata.org/entity/Q33588560

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@ast

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@en

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@nl

type

label

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@ast

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@en

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@nl

prefLabel

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@ast

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@en

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@nl

P1433

Q33588560-ADB72F65-B636-4D3F-B142-753EE882AE70

P1476

Q33588560-7B108CFB-652B-4C9F-B234-207C088BA0B2

P2093

Q33588560-1342D70B-5FBB-43ED-B795-ECC43BB7F172

Q33588560-1A00A106-D165-4623-A9F7-0C1D82187B6F

Q33588560-5C897B24-C7B1-4CB7-A9E5-F36E516E7AF3

Q33588560-7ED88629-E19F-4BBD-856B-84E5F2F5DEB2

Q33588560-8F19C074-E6ED-4FE9-94A1-091D039F1CBB

Q33588560-A357576D-9166-419E-ADDE-B3926657273E

Q33588560-AB2C17CB-60AD-482B-A4E5-FB4019EDC607

Q33588560-B1FEDDF8-34D3-4AE8-A2C6-08457F19BE11

Q33588560-B31A9C13-E885-4443-B0E7-703711D49E74

Q33588560-B8539836-E489-4544-A5A9-6BE7F3FCB578

P2860

Q33588560-14A7CCD8-4A12-4BA1-9231-0D3E8E7D93DC

Q33588560-164DC1AF-883B-4C7C-BCBF-DC041D4DD926

Q33588560-1704948C-8C59-45F1-A546-1B04E38DC92C

Q33588560-1CD43DD1-7BE1-4CE2-B1B6-4E12216599FA

Q33588560-2EA63A6D-71BF-48A2-A27A-87BB6C80E890

Q33588560-33DDB63F-D736-4887-B6A4-F82FAF0B86EA

Q33588560-456E7B94-7672-4F8E-8BF6-58664A669697

Q33588560-4AE8512D-15F9-4338-8D06-B7D15ED04B79

Q33588560-4C02B840-6CF1-459A-91CB-5E47158C4BBF

Q33588560-4D212A79-B74C-41BC-8C52-7175E9AD426E

P304

Q33588560-D3A5F99E-C3E8-46E0-AAFB-8F1A41A238AC

P31

Q33588560-4D47EAAE-185C-4E86-8699-3FCBB0E14F21

P356

Q33588560-CDFC6F2B-C5B4-47C9-976E-549DC89609B4

P407

Q33588560-56611E5E-F222-41F5-BC5E-A12BEB9319B7

P433

Q33588560-F71D39B1-E5D3-44BA-890F-0BB0416298B8

P478

Q33588560-9A8680C6-970D-4807-9B67-A785B6399635

P50

Q33588560-4A518C5D-253B-4E65-A72B-334501A4BF6B

Q33588560-AB69ED1A-3416-41BA-B0E2-AE0C243218E2

P577

Q33588560-BAEFF328-B63B-4540-AA30-0FECAE1DCCDD

P5875

Q33588560-522AD654-1567-4501-8740-3222967277D4

P698

Q33588560-E7DEBA1F-5D09-492A-A12E-A7E1E352EA88

P921

Q33588560-a4e84d90-d3c6-48ce-90e7-1c66453102ee

P932

Q33588560-117DC17B-8E66-4F36-8A98-6709C3EFC503

P356

JOURNAL.PONE.0010734

P1433

P1476

Toll-like receptor 4 promoter ...... evere urinary tract infection.

@en

P2093

Alexander Urbano

http://www.w3.org/2001/XMLSchema#string

Ann-Charlotte Lundstedt

http://www.w3.org/2001/XMLSchema#string

Björn Andersson

http://www.w3.org/2001/XMLSchema#string

Björn Wullt

http://www.w3.org/2001/XMLSchema#string

Bryndís Ragnarsdóttir

http://www.w3.org/2001/XMLSchema#string

Catharina Svanborg

http://www.w3.org/2001/XMLSchema#string

Irene Leijonhufvud

http://www.w3.org/2001/XMLSchema#string

Jenny Grönberg-Hernandez

http://www.w3.org/2001/XMLSchema#string

Klas Jönsson

http://www.w3.org/2001/XMLSchema#string

Lennart Truedsson

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

Consed: a graphical tool for sequence finishing

PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene

Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

Toll-like receptor control of the adaptive immune responses

P304

e10734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0010734

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Mattias Gustafsson

P577

2010-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44633421

http://www.w3.org/2001/XMLSchema#string

P698

20505764

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

2873976

http://www.w3.org/2001/XMLSchema#string